Genflow Biosciences (OTCQB:GENFF) on Wednesday introduced that its second European patent utility (Utility No. 23821586.7, Publication No. EP4630038), titled “SIRT6 Variant for NASH,” has been revealed within the European Patent Bulletin.
Publication of the patent utility within the European Patent Bulletin follows entry into the European part underneath the Patent Cooperation Treaty and represents a key milestone in Genflow’s increasing mental property portfolio.
